These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32924828)

  • 21. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
    Jin L; Weiqian C; Lihuan Y
    Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked elevation of circulating CD19
    Li S; Ma F; Hao H; Wang D; Gao Y; Zhou J; Li F; Lin HC; Xiao X; Zeng Q
    Pediatr Neonatol; 2018 Jun; 59(3):296-304. PubMed ID: 29239829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD24
    Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
    Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
    Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
    Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.
    Zha B; Wang L; Liu X; Liu J; Chen Z; Xu J; Sheng L; Li Y; Chu Y
    PLoS One; 2012; 7(11):e49835. PubMed ID: 23189166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis.
    Guo S; Chen Q; Liang X; Mu M; He J; Fang Q; Song C; Sang D
    J Int Med Res; 2018 Sep; 46(9):3970-3978. PubMed ID: 30025488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles.
    Simon Q; Pers JO; Cornec D; Le Pottier L; Mageed RA; Hillion S
    J Allergy Clin Immunol; 2016 May; 137(5):1577-1584.e10. PubMed ID: 26525227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus.
    Zhu HQ; Xu RC; Chen YY; Yuan HJ; Cao H; Zhao XQ; Zheng J; Wang Y; Pan M
    Br J Dermatol; 2015 Jan; 172(1):101-10. PubMed ID: 24935080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in the proportion of CD24
    Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
    Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic Signature of the CD24
    Bigot J; Pilon C; Matignon M; Grondin C; Leibler C; Aissat A; Pirenne F; Cohen JL; Grimbert P
    Am J Transplant; 2016 Dec; 16(12):3430-3442. PubMed ID: 27273606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
    Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
    Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The response of CD27
    Zhu Y; Jiang Q; Lei C; Yu Q; Qiu L
    BMC Pediatr; 2024 Feb; 24(1):154. PubMed ID: 38424520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and immunophenotypic characterization of human B cells with regulatory functions.
    de Masson A; Le Buanec H; Bouaziz JD
    Methods Mol Biol; 2014; 1190():45-52. PubMed ID: 25015272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of CD19
    Zhao Q; Jung LK
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD24
    Hasan MM; Thompson-Snipes L; Klintmalm G; Demetris AJ; O'Leary J; Oh S; Joo H
    J Immunol; 2019 Oct; 203(8):2110-2120. PubMed ID: 31511354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
    Lin S; Ma Z; Huang Y; Sun Y; Yi H
    Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus.
    Menon M; Blair PA; Isenberg DA; Mauri C
    Immunity; 2016 Mar; 44(3):683-697. PubMed ID: 26968426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
    Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
    Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.